intoplicine has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisagni, E; Bissery, MC; Lavelle, F; Lhoste, JM; Nguyen, CH | 1 |
| Bisagni, E; Bissery, MC; Lavelle, F; Nguyen, CH; Vrignaud, P | 1 |
2 other study(ies) available for intoplicine and Experimental Leukemia
| Article | Year |
|---|---|
Synthesis and antitumor activity of 1-[[(dialkylamino)alkyl]amino]-4-methyl-5H-pyrido[4,3-b]benzo[e]- and -benzo[g])indoles. A new class of antineoplastic agents.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Leukemia, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Pyridines; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.
Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Drug Resistance; Drug Screening Assays, Antitumor; Female; Indoles; Leukemia, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Pyridines; Topoisomerase I Inhibitors | 1993 |